好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Morbidity and Mortality Conferences in ACGME Core Competencies 好色先生 for Neurology Residents
Neurologic 好色先生
P04 - (-)
248
BACKGROUND: Morbidity and mortality (MM) conferences are routinely held in many specialties of medicine and surgery for teaching and quality improvement. The role of MM conferences in teaching of Accreditation Council of Graduate medical 好色先生 (ACGME) core competencies for neurology residents has not been systematically studied.
DESIGN/METHODS: MM presentations prepared by senior neurology residents during one academic year at Massachusetts General Hospital and Brigham and Women's Hospital were retrieved and data were extracted for patient census, mortalities and morbidities, and diagnostic classification. Individual morbidities and mortalities were reviewed to identify instances where an ACGME core competency was addressed during the case discussion.&The six core competencies were patient care, medical knowledge, practice based learning and improvement, systems based practice, professionalism and interpersonal skills and communication, as identified by the ACGME (www.acgme-nas.org).
RESULTS: A cumulative census of 3,694 inpatients admitted to 4 neurology inpatient services in the Partners Healthcare System was presented in 49 Morbidity and Mortality presentations made over a period of 1 academic year. There were 227 teaching instances identified where an ACGME core competency was addressed. Patient care and medical knowledge issues were explicitly addressed in 48.9% of instances (19.4 and 29.5% respectively); systems based practice in 15.8%; communication in 19%; and practice based learning and professionalism in 8.5% each.
CONCLUSIONS: Morbidity and Mortality conferences provide a rich forum in which all of the ACGME core competencies in neurology are addressed.
Authors/Disclosures
Tarun Singhal, MD (Brigham And Women's Hospital)
PRESENTER 		Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme Sanofi. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana LifeSciences. The institution of Dr. Singhal has received research support from Novartis. The institution of Dr. Singhal has received research support from Department of Defense. The institution of Dr. Singhal has received research support from Foundation for Neurologic Diseases.
Kevin N. Sheth, MD, FAAN (Yale UniversityDivision of Neuro and Critical Care) Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Tracey Cho, MD, FAAN Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Delve Bio. Dr. Cho has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of an immediate family member of Dr. Cho has received research support from NIH. Dr. Cho has received publishing royalties from a publication relating to health care.
No disclosure on file